Who are Vitamin B12 and folic acid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Vitamins: Folic acid, B6, B12, Vitamins E + C, Amlodipine-folic acid placebos, Calcichew D3, ZENTEL and Vitamin A Soft Capsules, Folic acid, vit B12.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/vitamin-b12-and-folic-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Vitamin B12 and folic acid — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin B12 and folic acid (Vitamin B12 and folic acid) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin supplement. Area: Hematology / Nutritional deficiency.

marketed Vitamin supplement Hematology / Nutritional deficiency Small molecule Live · refreshed every 30 min

Target snapshot

Vitamin B12 and folic acid (Vitamin B12 and folic acid) — Washington University School of Medicine. Vitamin B12 and folic acid are essential cofactors that support DNA synthesis, cell division, and neurological function by facilitating one-carbon transfer reactions.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Vitamin B12 and folic acid TARGET	Vitamin B12 and folic acid	Washington University School of Medicine	marketed	Vitamin supplement
Vitamins: Folic acid, B6, B12	Vitamins: Folic acid, B6, B12	Hamilton Health Sciences Corporation	marketed	Vitamin supplement / B-complex
Vitamins E + C	Vitamins E + C	University Hospital, Aker	marketed	Vitamin supplement / Antioxidant combination
Amlodipine-folic acid placebos	Amlodipine-folic acid placebos	Shenzhen Ausa Pharmed Co.,Ltd	marketed	Calcium channel blocker with vitamin supplement	L-type calcium channel (amlodipine); folate metabolism (folic acid)
Calcichew D3	Calcichew D3	Takeda	marketed	Mineral supplement / Vitamin supplement combination
ZENTEL and Vitamin A Soft Capsules	ZENTEL and Vitamin A Soft Capsules	Chengdu Maternal and Children's Health Care Hospital	marketed	Anthelmintic + Vitamin supplement	β-tubulin (albendazole component)
Folic acid, vit B12	Folic acid, vit B12	AGUNCO Obstetrics and Gynecology Centre	marketed	Vitamin supplement combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin supplement class)

Ain Shams University · 1 drug in this class
CHU de Quebec-Universite Laval · 1 drug in this class
First Affiliated Hospital Xi'an Jiaotong University · 1 drug in this class
Fundação Educacional Serra dos Órgãos · 1 drug in this class
M.D. Anderson Cancer Center · 1 drug in this class
Washington University School of Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vitamin B12 and folic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-b12-and-folic-acid. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab